I am glad Rae is now involved with the deal making.
I was hoping Samsung Biologics, or its parent, would invest given the characterization of leronlim
ab, by its CEO, as a "potential blockbuster. "
One would think some company would be willing to invest given the potential for success, and low stock price.
Given that so many biopharmas with seemingly much less potential get licensing deals or buyouts, it is disappointing that nothing like that has as yet come to fruition.
I remain hopeful, we will one day wake up to read a life changing PR that Cytodyn has been purchased.
LM
Market Data 
Markets 
AI
